131 related articles for article (PubMed ID: 7858153)
1. Autocrine and paracrine functions of cytokines in malignant lymphomas.
Hsu SM; Hsu PL
Biomed Pharmacother; 1994; 48(10):433-44. PubMed ID: 7858153
[TBL] [Abstract][Full Text] [Related]
2. Cytokines in malignant lymphomas: review and prospective evaluation.
Hsu SM; Waldron JW; Hsu PL; Hough AJ
Hum Pathol; 1993 Oct; 24(10):1040-57. PubMed ID: 8406414
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. 1. unique cytokine and cytokine receptor profile distinguished from that of non-hodgkin's lymphomas.
Hsu SM; Waldron J; Xie SS; Hsu PL
J Biomed Sci; 1995 Oct; 2(4):302-313. PubMed ID: 11725067
[TBL] [Abstract][Full Text] [Related]
4. Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth.
Merz H; Fliedner A; Orscheschek K; Binder T; Sebald W; Müller-Hermelink HK; Feller AC
Am J Pathol; 1991 Nov; 139(5):1173-80. PubMed ID: 1951632
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
Hsu SM; Xie SS; Hsu PL; Waldron JA
Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic cytokines in lymphoproliferative disorders: multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia.
Ohshima KHaraoka S; Suzumiya J; Kawasaki C; Kanda M; Kikuchi M
Leuk Lymphoma; 2000 Aug; 38(5-6):541-5. PubMed ID: 10953975
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma].
Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ
Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251
[TBL] [Abstract][Full Text] [Related]
8. Cell dynamics and expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma.
Yamaguchi S; Kitagawa M; Inoue M; Tomizawa N; Kamiyama R; Hirokawa K
Exp Mol Pathol; 2000 Apr; 68(2):85-94. PubMed ID: 10716912
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic significance of interleukin-6 in angioimmunoblastic lymphadenopathy-type T-cell lymphoma.
Hsu SM; Waldron JA; Fink L; King C; Xie SS; Mansouri A; Barlogie B
Hum Pathol; 1993 Feb; 24(2):126-31. PubMed ID: 8432509
[TBL] [Abstract][Full Text] [Related]
10. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma.
Merz H; Houssiau FA; Orscheschek K; Renauld JC; Fliedner A; Herin M; Noel H; Kadin M; Mueller-Hermelink HK; Van Snick J
Blood; 1991 Sep; 78(5):1311-7. PubMed ID: 1908723
[TBL] [Abstract][Full Text] [Related]
12. Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type.
Foss HD; Anagnostopoulos I; Herbst H; Grebe M; Ziemann K; Hummel M; Stein H
Blood; 1995 May; 85(10):2862-9. PubMed ID: 7742548
[TBL] [Abstract][Full Text] [Related]
13. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease.
Hsu SM; Lin J; Xie SS; Hsu PL; Rich S
Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031
[TBL] [Abstract][Full Text] [Related]
14. Abundance of heat shock proteins (hsp89, hsp60, and hsp27) in malignant cells of Hodgkin's disease.
Hsu PL; Hsu SM
Cancer Res; 1998 Dec; 58(23):5507-13. PubMed ID: 9850087
[TBL] [Abstract][Full Text] [Related]
15. Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma.
Takeshita M; Sumiyoshi Y; Masuda Y; Ohshima K; Yoshida T; Kikuchi M; Müller H
Pathol Res Pract; 1993 Feb; 189(1):18-25. PubMed ID: 8516212
[TBL] [Abstract][Full Text] [Related]
16. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
[TBL] [Abstract][Full Text] [Related]
17. [Paraneoplastic lymphadenopathy].
Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. ii. from cytokines to cell lineage.
Hsu SM; Waldron J; Xie SS; Hsu PL
J Biomed Sci; 1996 Jan; 3(1):1-13. PubMed ID: 11725077
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice.
Bargou RC; Mapara MY; Zugck C; Daniel PT; Pawlita M; Döhner H; Dörken B
J Exp Med; 1993 May; 177(5):1257-68. PubMed ID: 8386741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
